In addition, database analysis revealed that among the six enzymes, both ACSS2 and ACADS were down-regulated in cancer tissues (Fig. 2E), and low ACSS2 expression was associated with poor outcomes in breast cancer patients (fig. Here, ACSS2 is linked to breast carcinoma.